SpringWorks Therapeutics Inc (NASDAQ: SWTX) kicked off on Friday, up 0.13% from the previous trading day, before settling in for the closing price of $46.20. Over the past 52 weeks, SWTX has traded in a range of $28.21-$62.00.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 663.47% over the last five years. While this was happening, its average annual earnings per share was recorded 26.67%. With a float of $71.17 million, this company’s outstanding shares have now reached $74.99 million.
The firm has a total of 368 workers. Let’s measure their productivity. In terms of profitability, gross margin is 93.07%, operating margin of -145.17%, and the pretax margin is -134.73%.
SpringWorks Therapeutics Inc (SWTX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of SpringWorks Therapeutics Inc is 5.14%, while institutional ownership is 105.99%. The most recent insider transaction that took place on Mar 03 ’25, was worth 1,084,592. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $54.23, taking the stock ownership to the 169,712 shares. Before that another transaction happened on Mar 03 ’25, when Company’s Chief Executive Officer sold 49,000 for $54.24, making the entire transaction worth $2,657,656. This insider now owns 954,869 shares in total.
SpringWorks Therapeutics Inc (SWTX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 26.67% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
Take a look at SpringWorks Therapeutics Inc’s (SWTX) current performance indicators. Last quarter, stock had a quick ratio of 4.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.80.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.41, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach -0.80 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Analysing the last 5-days average volume posted by the [SpringWorks Therapeutics Inc, SWTX], we can find that recorded value of 5.27 million was better than the volume posted last year of 3.93 million. As of the previous 9 days, the stock’s Stochastic %D was 78.74%. Additionally, its Average True Range was 1.49.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 47.61%, which indicates a significant decrease from 99.46% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.71% in the past 14 days, which was lower than the 83.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $45.39, while its 200-day Moving Average is $39.71. Now, the first resistance to watch is $46.29. This is followed by the second major resistance level at $46.33. The third major resistance level sits at $46.39. If the price goes on to break the first support level at $46.19, it is likely to go to the next support level at $46.13. Should the price break the second support level, the third support level stands at $46.09.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
The company with the Market Capitalisation of 3.47 billion has total of 74,984K Shares Outstanding. Its annual sales at the moment are 191,590 K in contrast with the sum of -258,130 K annual income. Company’s last quarter sales were recorded 61,550 K and last quarter income was -77,300 K.
